Inflammatory bowel disease. Part II.
D001379:Azathioprine / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D006801:Humans; D010919:Placebos; D011241:Prednisone / Q000627:therapeutic use*; D012460:Sulfasalazine / Q000627:therapeutic use*
D010919:Placebos; D012460:Sulfasalazine; D001379:Azathioprine; D011241:Prednisone